Mark Kronenfeld

Mark Kronenfeld

Directeur/Membre du Conseil chez PACIRA BIOSCIENCES, INC.

Fortune : 721 329 $ au 31/05/2026

71 ans
Finance
Consumer Services
Health Services

Profil

Mark A. Kronenfeld was the founder of Ridgemark Capital Management LLC, founded in 2001, where the title held was Managing Partner & Portfolio Manager from 2001 to 2008.
Dr. Kronenfeld is also the founder of GMS Anesthesia Associates..
Dr. Kronenfeld currently holds the position of Chairman-Anesthesiology at Maimonides Medical Center since 2022.
The role of Independent Director at Pacira Biosciences, Inc. has been held since 2013.
Dr. Kronenfeld is an Assistant Professor at New York University.
Managing Partner roles are held at the American Association of Bovine Practitioners, Strategic Medical Partners, SORADS LLP, Anesthesiology Associates of Boro Park LLP, and Strategic Medical Management Partners LLC.
Former positions include Senior Managing Director at C.
E.
Unterberg, Towbin Advisors LP; Senior Managing Director at Collins Stewart LLC (Investment Management) from 2007 to 2008; Principal at Tudor Investment Corp.; and Chief-Cardiac Anesthesiology at HMH Hospitals Corp, Inc. Education includes undergraduate studies at State University of New York at Buffalo and a doctorate from UC San Diego School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/04/2026 31 065 ( 0,08% ) 721 329 $ 31/05/2026

Postes actifs de Mark Kronenfeld

SociétésPosteDébut
PACIRA BIOSCIENCES, INC. Directeur/Membre du Conseil 12/06/2013
Corporate Officer/Principal 01/03/2009
Strategic Medical Partners
Corporate Officer/Principal -
American Association of Bovine Practitioners
Corporate Officer/Principal -
SORADS LLP
Corporate Officer/Principal -
Anesthesiology Associates of Boro Park LLP
Corporate Officer/Principal -
Corporate Officer/Principal -
Strategic Medical Management Partners LLC
Corporate Officer/Principal -

Anciens postes connus de Mark Kronenfeld

SociétésPosteFin
Gestionnaire de Portefeuille-Actions 31/12/2008
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░ ░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ -
░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Mark Kronenfeld

Formation de Mark Kronenfeld

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Finance

Finance

Health Technology

Consumer Services

Consumer Services

Health Services

Health Services

Finance

American Association of Bovine Practitioners

Strategic Medical Partners

SORADS LLP

Consumer Services

Anesthesiology Associates of Boro Park LLP

Ridgemark Capital Management LLC

GMS Anesthesia Associates

Strategic Medical Management Partners LLC

  1. Bourse
  2. Insiders
  3. Mark Kronenfeld